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Intensive Care Medicine is changing. New types of
papers, such as ‘‘What’s New in Intensive Care?’’,
‘‘Understanding the Disease’’ and ‘‘My Paper 20 Years
Later’’, form a stable proportion of the articles published
in the 2014 issues. This diversification has been received
with an extraordinary enthusiasm and appreciation by the
worldwide readership, as evidenced by the massive
number of hits and downloads. In this first of three 2014
‘‘Year in Review’’ articles, we cover those papers pub-
lished in Intensive Care Medicine during the past year
which focus on cardiac arrest, ultrasonography in criti-
cally ill patients, neurocritical care, ICU-acquired
weakness, nutrition, acute kidney injury, as well as a
number of miscellaneous topics.
Cardiac dysfunction in the intensive care unit
Two articles falling in the category ‘‘My paper 20 Years
Later’’ highlighted two timeless cardiovascular topics,
namely, the VO2/DO2 relationship and weaning-induced
cardiac dysfunction.
In the first of these articles, Vincent and De Backer [1]
appraised a paper [2] they had published in 2002 assess-
ing the presence of VO2/DO2 dependency using a
dobutamine test. In the 2014 article, the authors critically
re-evaluated the VO2/DO2 relationship. Under normal
conditions, oxygen uptake (VO2) is independent of oxy-
gen delivery (DO2) because O2 extraction rapidly adapts
to changes in DO2. However, VO2 can become DO2
dependent in acute circulatory failure. The VO2/DO2
relationship is thus a major parameter in guiding therapy
of acute circulatory failure at the bedside, even though its
application in past years may now be viewed as rather
toosimplistic given present-day knowledge. Vincent and
De Backer [1] summarize our current understanding of
the VO2/DO2 relationship in critically ill patients in
simple take-home messages. First, abnormal global VO2/
DO2 dependency does not exist in stable, critically ill
patients, including those with sepsis or acute respiratory
distress syndrome (ARDS). Secondly, abnormal global
VO2/DO2 dependency does exist in severe cases of cir-
culatory shock, when blood flow is significantly reduced,
and it may exist globally in patients with septic shock and
regionally in patients with severe sepsis. Thirdly, due to
microcirculatory alterations, global determinations of
VO2/DO2 are unfortunately insufficiently precise/sensitive
to guide therapy effectively, and regional measurements
cannot be obtained routinely in critically ill patients.
Lastly, the study of the time-course of blood lactate levels
may represent a surrogate for the evaluation of cellular
oxygen deficit.
In the second cardiovascular review highlighted here,
Teboul [3] evaluated the impact of an article published in
1988 [4] that introduced the concept of weaning-induced
cardiac dysfunction. Since publication of the latter article,
weaning-induced cardiac dysfunction has been realized as
an established cause of weaning failure, and relevant
clinical research studies have made major contributions
towards improving its diagnosis. Concepts have evolved
greatly over the last 25 years, and present-day ICU
physicians are well aware that weaning failure may be
partially or completely due to an acute onset of cardio-
genic pulmonary edema. Efforts should be made not only
to accurately diagnose cardiogenic pulmonary edema but
also identify the mechanisms responsible for its devel-
opment during weaning. Ongoing and future
technological progress in ultrasonography and biomarker
research will certainly help identify this condition.
On the educational side, Perel and colleagues [5]
contributed a very interesting article to ‘‘My Paper
20 Years later’’ in which they describe the evolution of
the concept of respiratory variations in arterial pressure
during mechanical ventilation, covering the period from
the publication of their 1987 landmark paper until present
day. This comprehensive review may help readers to
understand the physiology of this phenomenon, specifi-
cally in terms of the clinical applications and limitations
of dDown [delta down; decrease in the systolic blood
pressure (SBP)] and dUp (delta up; increase in the SBP),
the two main components of respiratory variations in
arterial pressure. These authors also note that decisions
regarding hemodynamic management should be based on
the integration of parameters of various sources and not
on any single parameter, taking into consideration the
entire clinical and physiological picture.
In a ‘‘What’s New in Intensive Care?’’ paper, Dalabih
and colleagues discuss the management of acute right
ventricular decompensation of chronic pulmonary
hypertension [6] in which readers are reminded that
reducing or limiting right ventricular afterload is the key
to good clinical management, regardless of the etiology.
The paper includes a well-designed figure summarizing
the challenges and the recommendations of good clinical
management of this entity, including some which concern
mechanical ventilation strategies.
For the entire period of recorded human history, the
world has never been globally as aged as today. It is
therefore not surprising that the proportion of elderly
patients admitted to the ICU is increasing, even in cir-
culatory shock. The usefulness of ICU admission in the
aged population is a hot topic worldwide. Mortality rates
are known to increase with age, but the impact of age on
outcomes after circulatory shock has not been well
defined. Biston et al. [7] explored this topic, performing a
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secondary analysis of data from a large randomized trial
that compared the effects of dopamine and norepinephrine
on outcome in the ICU. Mortality rates were higher in
elderly (75–84 years) and very elderly (C85 years)
patients at 28 days, at hospital discharge and after 6 and
12 months of follow-up. Most very elderly patients were
dead at 6 (92 %) and 12 months (97 %). Mortality rates
increased with age in all types of shock. Using multi-
variable analysis, the risk of death was higher in very
elderly patients as compared to patients aged \75 years.
In this analysis, ageing is independently associated with
higher mortality rates in patients with circulatory failure,
whatever the etiology. By 1 year after admission, most
patients aged [85 years had died.
Assessment of the central venous-to-arterial carbon
dioxide difference [P(v–a)CO2] seems to be helpful in
assessing the adequacy of the cardiac index (CI) to
oxygen demand when incremental doses of dobutamine
are infused into patients with stable chronic heart fail-
ure. Whether such phenomena can be observed in stable
septic shock patients is presently not known. Moreover,
it has been demonstrated that P[v–a]CO2 can be
substituted by the central venous-to-arterial CO2 differ-
ence (DPCO2) in critically ill patients. Mallat at al. [8]
tried to solve this conundrum by assessing the behavior
of DPCO2, an index of the CO2 production (VCO2)/CI
ratio, in hemodynamically stable septic shock patients,
but with ongoing signs of tissue hypoperfusion, given
incremental doses of dobutamine. Twenty-two hemo-
dynamically stable septic shock patients with no signs
of global tissue hypoxia, with normal blood lactate
levels, were enrolled in their prospective study. Despite
a dose-related increase in CI and DO2, dobutamine
infusion did not result in a dose-dependent decrease in
DPCO2, and VO2 and VCO2 showed a statistically sig-
nificant increase in parallel with the increased doses of
dobutamine. The authors concluded that the measure-
ment of DPCO2 may be a useful tool to assess the
adequacy of oxygen supply to metabolic and oxygen
demand.
Schmidt at al. [9] retrospectively evaluated the impact
of fluid balance (FB) on day-90 mortality in a cohort of
115 adult patients treated with extracorporeal membrane
oxygenation (ECMO) for refractory heart failure and 57
patients treated with ECMO for refractory respiratory
failure. Early positive FB, especially at day 3, was found
to be a robust and independent predictor of 90-day
mortality, regardless of the primary diagnosis, acute
kidney injury (AKI) or renal replacement therapy (RRT)
use. In addition, these authors confirmed that AKI during
ECMO is frequent and that those patients requiring
continuous RRT are at greater risk of mortality. The
conclusion drawn by the authors was that prospective
studies of tight FB control over the first 5 days of ECMO
are warranted.
Cardiac arrest
Hypothermia remains a hot topic in cardiac arrest (CA)
management. In a 7-day profile publication, Debaty et al.
[10] report a randomized multicenter study of the impact
of intra-arrest therapeutic hypothermia (IATH, 34 C) in
out-of-hospital cardiac arrest (OHCA) patients. In the
control group (122 patients), cooling was performed as
usual, i.e. as soon as possible after hospital admission,
whereas in the interventional group (123 patients) patients
received an infusion of cold saline with external cooling
during cardiopulmonary resuscitation (CPR). Patients
were included in the study whatever the initial rhythm,
even though a large proportion of patients had a non-
shockable rhythm. IATH did not have any significant
effect on laboratory markers of inflammation and brain
damage (neuron-specific enolase at 24 h) or on outcome,
even though the target temperature was achieved earlier
in the interventional group. No side effect of IATH was
reported.
Severe neurological impairment secondary to hyp-
oxic–ischemic brain injury is common after resuscitation
from CA, and an early identification of patients with no
chance of good neurological outcome will help avoid
inappropriate treatment. Such prognostication is never
straightforward and is further complicated by the use of
mild therapeutic hypothermia. A recent Advisory State-
ment from the European Resuscitation Council and the
European Society of Intensive Care Medicine (ESICM)
provides evidence-based, expert consensus guidance on
prognostication in comatose survivors of CA [11]. Fol-
lowing a GRADE-based systematic review, expert
consensus was achieved using web-based Delphi meth-
odology. The quality of evidence was low or very low for
almost all of the 73 studies reviewed. A careful clinical
neurological examination, with adequate time allowed to
exclude confounding factors, remains the foundation for
prognostication of the comatose patient after CA. The
most robust predictors of poor prognosis are coma in
patients with absent or extensor posturing at C72 h after
CA (whether or not treated with MTH), bilateral absence
of pupillary or corneal reflexes and bilateral absence of
the N20 wave of somatosensory evoked potentials. Less
robust predictors include status myoclonus, elevated
neuron-specific enolase (NSE) at 48–72 h, non-reactive
electroencephalography (EEG) patterns after rewarming
and neuroimaging evidence of diffuse post-anoxic injury.
Prognostication using multiple variables is preferable but
often limited by the shortage of relevant investigations
and expertise. If the results of prognostic tests produce
conflicting results or prognostication remains uncertain,
further clinical observation and re-evaluation is
recommended.
Various biomarkers have also been used to assess the
severity of hypoxic brain injury and allow prognostication
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after CA, but the optimal biomarker and cut-off values are
uncertain and predictive abilities in the presence of MTH
uncertain. The neuropeptide secretoneurin (SN) is spe-
cifically expressed in neuronal tissues and has multiple
biological functions. It is upregulated by hypoxia and
therefore has potential as a novel biomarker for hypoxic
brain injury after CA. The prognostic value of SN was
recently investigated in a prospective observational study
of 134 patients admitted to an ICU after successful CPR
following CA [12]. There was on average a sixfold
increase in serum SN levels within the first 24 h after
CPR, with significantly higher levels in patients with a
poor neurological outcome compared to those with a good
neurological outcome. SN predicted outcome earlier than
NSE and is likely not influenced by MTH. It therefore has
the potential to be a superior biomarker for early neuro-
logical prognostication after CA.
Exploring large datasets could help improve our
understanding of the efficacy of various clinical inter-
ventions. Bougouin et al. [13] reported the very
interesting results of a large population-based registry on
sudden cardiac death in the greater Paris area, which is
home to [10 % of the general French population. Of the
7,238 cases of OHCA included in the registry over a
2-year period, 15 % were related to an extracardiac eti-
ology and 85 % (6,165) were of cardiac origin. Of these
patients, only 1,332 (22 %) were ultimately admitted to
hospital alive. Initial rhythm was shockable in 26 % of
cases, 58 % underwent coronary angiography and almost
the same proportion was treated by therapeutic hypo-
thermia. This study demonstrates that prognosis clearly
remains very poor, since only 4.5 % of the patients with
OHCA of cardiac origin (7.5 % of patients who actually
underwent attempted resuscitation and 21 % of patients
admitted alive) were discharged alive. Factors associated
with prognosis were bystander CPR and initial shockable
rhythm (increased survival), age, longer response time,
occurrence of cardiac arrest at home and epinephrine dose
of [3 mg during resuscitation (decreased survival).
Al-Alwan et al. [14] reported the incidence and
prognosis of CPR among patients already on mechanical
ventilation using patient data in the Finnish medicare
database between January 1994 and December 2005.
Among the 471,962 patients who received in-hospital
CPR during the period, 18.4 % survived. When CPR was
performed in patients already ventilated, survival at hos-
pital discharge was only 10.1 %, compared with 19.2 %
in patients not already ventilated. At the 1-year follow-up,
survival was 4.1 % in patients with CPR while ventilated.
ICU staff and family members discussing the manage-
ment of such patients should be aware of these results,
which should, however, be interpreted with caution in the
light of the paper discussed next.
Efendjev et al. [15] reported temporal trends in CA
incidence and outcome in Finnish ICUs from 2003 to
2013 using patient data in a large nationwide ICU
database and TISS-76 (Therapeutic Intervention Scoring
System 76) documentation. All patients who needed CPR
while admitted to the ICU for any reason other than
cardiac arrest (ICU-CA patients) were enrolled in this
study. The crude incidence of ICU-CA was 29/1,000
admissions, which decreased over time. Most ICU-CAs
occurred in non-operative cardiovascular patients, with
the vast majority (89 %) occurring during the first 3 days
in the ICU. Most patients (80 %) were ventilated. The
53.1 % in-hospital mortality decreased over the study
period.
Ultrasonography in critically ill patients
The potential benefits from point-of-care ultrasound (US)
and fair expectations about its utility in the ICU some-
times need to reconsidered given the general paucity of
the literature on the topic, mainly due to the relative
novelty of many applications of US. Three articles pub-
lished in Intensive Care Medicine last year (re)opened an
interesting pro/con debate on the use of echography for
the initial management of critically ill patients [16–18].
An important aspect of the clinical application(s) of
each new technological development is training at the
bedside. After a statement published in Intensive Care
Medicine in 2011 [19], the same group of experts pub-
lished the results of a round table [20] held in Paris in
2013 during the ESICM congress. The 2014 international
statement reports detailed training standards for advanced
critical care echocardiography which should form the
basis of future European certification in advanced critical
care echocardiography.
In a prospective single-center study, Nguyen et al. [21]
determined the learning curve of 30 intensivists per-
forming US-guided jugular central venous catheter
placement after a training program which included
30 min of instruction and a 7-min-video to illustrate the
procedure and the manipulation of the probe. The learning
curve was evaluated using two scoring systems, with the
first evaluating preparation (with sterile cover and
manipulation of the probe) and the second evaluating
technical skills (vessel identification, needle visualization,
internal jugular puncture and guide insertion, among
others). The authors also recorded the time required for
the procedure. The findings demonstrated that he required
skills were easily acquired after an average of six to eight
procedures. Total time needed for catheter placement,
from arrival of the US machine in the patient’s room to
dressing, was 21 min after eight procedures.
Volpicelli et al. [22] performed a single-center pro-
spective study to determine the ability of lung
ultrasonography (LUS) to approximately quantify pneu-
mothorax volume, using the projection of the lung point
on the chest; the results were compared with
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measurements made using computed tomography (CT)
scan (59 patients) and/or chest X-ray (94 patients).
Trained operators performed LUS. A total of 124 spon-
taneously breathing patients with previously diagnosed
pneumothorax were consecutively enrolled in the study.
The authors reported that projection of the lung point on
the chest appears to be a useful predictor of pneumotho-
rax volume and that LUS can reliably classify the
pneumothorax as small or large. Following publication of
this paper, however, interesting items of correspondence
were published in Intensive Care Medicine which shed
light on the potential limitations of this approach [23, 24].
In a single-center prospective study, Begot et al. [25]
assessed the ability of resident novices in LUS to identify
and quantify unloculated pleural effusion after a limited
training program (1 h of instruction, 30 min of illustrative
cases and 90 min of tutored hands-on focus on the iden-
tification and quantification of pleural effusions) and
compared this ability with that of intensivists experienced
in the field. Quantification was based on the maximal
interpleural distance. Twelve residents examined 147
patients with suspected pleural effusion, leading to a
mean of 15 ± 9 evaluations per resident. Agreement
between resident novices and experienced intensivists
was considered as good to excellent for diagnosis in both
lungs. Agreement was also excellent for interpleural
space measurement.
Finally, based on the results of a single-center pro-
spective study with 45 blunt trauma patients, Leblanc
et al. [26] reported that the extent of lung contusion
quantified by trained operators using a predefined LUS
score is a good predictor of the occurrence of ARDS using
the Berlin definition [27] in the following 3 days. The
extent of lung contusion on LUS was also well correlated
with CT scan measurements. In addition, the authors
confirmed the performance of LUS for the diagnosis of
other injuries in this context, such as pneumothorax and
hemothorax.
Acute neurological illness in the ICU
The pathophysiology and management of several acute
neurological disorders have been reviewed in Intensive
Care Medicine in 2014. MacDonald et al. [28] recently
reviewed the pathophysiology of aneurysmal subarach-
noid hemorrhage (SAH). This review, which appears in
the ‘‘Understanding the Disease’’ series highlights how
early brain injury impacts on mortality. This injury is
related to the immediate effects of aneurysm rupture, and
the subsequent cellular, metabolic and inflammatory
consequences that result in impaired neurovascular cou-
pling, disruption of the blood–brain barrier, cerebral
ischemia and cerebral edema. New insights into the
pathogenesis of delayed cerebral ischemia and the
importance of early identification and effective treatment
to minimize poor outcome are discussed. The importance
of SAH-related systemic inflammatory response and car-
diovascular and respiratory complications are also
highlighted.
Increasing numbers of patients with acute ischemic
stroke (AIS) are being admitted to the ICU for aggressive
physiological optimization and management of post-
stroke complications, including those related to throm-
bolytic therapy, as well as patients receiving recently
released treatments. Although there are detailed European
and US Guidance for the management of AIS, very little
of this focuses on ICU management. A recent, structured
narrative review provides key recommendations for the
critical care management of AIS [29]. In addition to the
four interventions supported by class I evidence (care by a
multidisciplinary team in a stroke unit, intravenous tissue
plasminogen activator within 4.5 h of thrombotic stroke
onset, aspirin within 48 h of stroke onset and decom-
pressive craniectomy for malignant middle cerebral artery
infarction), the authors provide their own recommenda-
tions, based on the best available evidence, on airway and
ventilation management, hemodynamic and fluid optimi-
zation, fever and glycemic control, management of
anticoagulation, antiplatelet and thromboprophylaxis
therapy and control of seizures.
Status epileptic (SE) is the second most common life-
threatening neurological emergency (after AIS) and car-
ries a high risk of mortality and morbidity. In an article
entitled ‘‘What’s new in status epilepticus’’, Rossetti and
Bleck [30] review contemporary management and novel
therapies of SE. The crucial importance of rapid seizure
control is emphasized, and the authors’ recommendations
for three sequential—and escalating—lines of treatment
are discussed in detail. The role of newer third-line
therapies, such as ketamine, is debated.
Determining the line between life and death, whether
diagnosed by cardiorespiratory or neurological criteria, is
crucial. Indeed, death is pronounced not only because
further treatment is inappropriate, but also because soci-
ety requires confirmation of this event with certainty.
Advances in medicine and technology have made it
possible to support or replace failing organs in many
circumstances, challenging commonly held notions of the
biology of death and the dying process. Although
[40 years have past since the concept of brain death was
introduced into clinical practice, many of the controver-
sies that surround it have not been settled, particularly
with regard to the inevitable association between brain
death and organ donation. Truog and Miller [31] debate
these issues within the context of organ donation and the
‘‘dead donor rule’’. It has been argued that brain death
does not cohere with a biological or scientific under-
standing of death, although there is an intuitive
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plausibility and scientific support that patients who are
irreversibly comatose and apneic are dead.
There have been increasing calls for international
standardization of the determination of death diagnosed
by both cardiorespiratory and neurological criteria, and
for agreement on precise terminology to improve clarity
in discussions and debate about death. A recent report
summarizes the first phase in the development of such
international standards [32]. A single operational defini-
tion of death based on clear biomedical standards—rather
than anatomically based terms such as ‘‘cardiac’’ or
‘‘brain’’ death—has been proposed. The Working Party
recommended that death be defined as ‘‘the permanent
loss of the capacity for consciousness and all brain stem
functions as a consequence of permanent cessation of the
circulation or catastrophic brain injury’’. This recom-
mendation fulfills the requirement for determining death
using clinical criteria based on direct observation or
examination of the patient after specified preconditions
have been fulfilled and reinforced the exclusion of con-
founding factors. The next phase of this work, to include
broader representation of international stakeholders, will
develop clinical practice guidelines for the determination
of death.
Neuromonitoring
Some patients are admitted to an ICU for the management
of an acute neurological insult, such as traumatic, hem-
orrhagic or ischemic brain injury, whereas many others
develop brain dysfunction as a consequence of their
underlying critical illness. Monitoring the brain and
neurological function, therefore, is of major relevance in
the critical care setting. Fundamental to neurological
monitoring is serial clinical assessment of neurological
status. A pragmatic approach to the neurological exami-
nation of critically ill patients was recently published by
an Expert Panel of the ESICM [33]. This Consensus
Statement highlights the importance of conducting a full
clinical neurological examination in all ICU patients,
stressing that this should include the assessment of con-
sciousness and cognition and the examination of brain
stem and motor function. Daily sedation holds to allow
the assessment of neurological function are recommended
in all patients except those with reduced intracranial
compliance. The Guidance highlights the importance of
the Glasgow coma score (GCS) as a standardized, inter-
nationally recognized method for evaluating a patient’s
global neurological status. In association with the identi-
fication and documentation of localizing signs, such as
pupil responses and limb weaknesses, the GCS remains
the mainstay of clinical assessment 40 years since its first
description. The main limitations of the GCS are that
verbal responses are not assessable in intubated patients,
and brainstem function is not directly considered. The
Guidance recommends that four scores, which have been
designed and validated to overcome these issues, can be
used to differentiate yet further patients with a GCS of 3,
although there is limited evidence that this approach has
greater inter-rater reliability or prognostic value than the
GCS alone.
Clinical assessment is limited in sedated patients and
those with decreased conscious level, and various devices
are available for neurological monitoring in such cir-
cumstances. Techniques which provide global or regional
monitoring of cerebral perfusion, oxygenation and meta-
bolic status are used in brain-injured patients to provide
early warning of impending cerebral hypoxia/ischemia
and metabolic distress. In 2014 the Neurocritical Care
Society and ESICM published comprehensive and con-
sensus-based Expert Guidance on multimodality
neuromonitoring [34]. A systematic literature review of
specific physiological processes that are relevant to the
management of critically ill neurological patients was
undertaken and used to formulate recommendations for
individual monitoring techniques. Multimodal monitoring
only has value when monitored outputs of brain physi-
ology are interpreted by skilled clinicians and used to
direct individualized therapeutic options.
Many neuromonitors are invasive and available only
in specialist neurocritical care units. Interest in the
development of non-invasive techniques that can be used
more widely has been growing, and non-invasive
assessment of intracranial pressure (ICP) is one such
technique. Sekhon et al. [35] investigated the relationship
between the measurement of optic nerve sheath diameter
(ONSD) by CT and the directly measured ICP in a ret-
rospective cohort study of 57 patients with severe
traumatic brain injury (TBI). ONSD was highly discrim-
inatory for the prediction of intracranial hypertension
(ICP C 20 vs. \20 mmHg), and more powerfully pre-
dictive of increased ICP than any other CT finding.
The value of EEG in the diagnosis and management of
clinical and non-convulsive seizures (NCSz) in patients
with primary neurological conditions is well established,
but it is now clear that all critically ill patients are at risk
for the development of NCSz. In a retrospective study,
Kurtz et al. [36] reviewed 154 surgical ICU patients
without primary neurological disease who underwent
continuous EEG monitoring because of altered mental
state. NCSz were identified in 16 % of these patients and
periodic epileptiform discharges in 29 %. One-third of the
patients with NCSz had non-convulsive status epilepticus
(NCSE), and all of these cases were septic. NCSz were
independently associated with poor outcome. There is
clearly an urgent need for large prospective studies to
determine not only the exact prevalence and clinical
impact of NCSz in critical care, but also to investigate
whether treatment will improve outcome. In the
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meantime, it is recommended that EEG monitoring be
undertaken to exclude NCSz and NCSE in any patient
with an unexplained or persisting altered consciousness.
ICU-acquired weakness
Critical illness polyneuropathy and myopathy (CIPNM)
are neuromuscular disorders that develop after admission
to an ICU and result in ICU-acquired weakness (ICUAW),
with adverse effects on both short- and long-term out-
comes, including delayed weaning from mechanical
ventilation, increased ICU and hospital length of stay and
increased mortality and long-term disability. The mecha-
nisms of ICUAW are multiple and not yet fully elucidated,
but a disturbed balance of myosin heavy chain (MyHC)
has been implicated in the pathogenesis of the myopathy.
To investigate this hypothesis further, Wollersheim et al.
[37] measured MyHC synthesis and degradation in skel-
etal muscle in 29 critically ill patients at high risk of
developing ICUAW. Open biopsy of the vastus lateralis
muscle for analysis of mRNA, protein content and cellular
ultrastructure by electron microscopy was performed at a
median time of 5 days after ICU admission. A second
biopsy was performed in the 22 patients who were still in
the ICU at a median time of 15 days after admission.
Time-dependent changes in myofiber architecture and
MyHC synthesis and degradation were correlated with
Medical Research Council (MRC)-rated muscle strength.
Control biopsies were obtained from aged-matched heal-
thy patients undergoing elective hip replacement surgery.
ICU-acquired muscle wasting was characterized by early
(day 5) disrupted myofiber ultrastructure and later (day 15)
atrophy of slow- and fast-twitch myofibers. A decrease
(compared to controls) in MyHC mRNA and protein
expression was present at day 5 and persisted at day 15.
This study supports the hypothesis that decreased syn-
thesis and increased degradation of MyHC contributes to
ICUAW and suggests that its pathogenesis is initiated very
early after the onset of critical illness.
Although often suspected clinically, the definitive
diagnosis of ICUAW relies on a structured clinical eval-
uation demonstrating decreased muscle strength assessed
using the MRC scale, on nerve conduction studies (NCS)
and on needle electromyography (EMG). Manual testing
of muscle strength requires an awake, cooperative patient,
and a comprehensive electrophysiological examination is
both time-consuming and physically uncomfortable for
awake patients. Moss and colleagues demonstrated that a
simplified approach to the electrophysiological assess-
ment of CIPNM, using a combination of unilateral
peroneal (motor) and sural (sensory) NCS, has 100 %
sensitivity and high specificity for the diagnosis of CIP-
NM [38]. These findings suggest that patients with normal
peroneal and sural NCS are very unlikely to have CIPNM
and that further testing with EMG is unlikely to alter that
conclusion. However, if these NCS are abnormal, the
diagnosis of CIPNM should be explored further with
comprehensive electrophysiological investigations. This
more streamlined approach to the diagnosis of CIPNM
may facilitate routine diagnostic testing and monitoring of
weakness in critically ill patients.
Lactate and the injured brain
Lactate has previously been considered to be a harmful
waste product of the cerebral anaerobic metabolism of
glucose, but it is now known to have possible beneficial
effects in the brain. Increased lactate after TBI may be the
consequence of increased cerebral glycolysis rather than
hypoxia/ischemia. Lactate can be ‘‘shuttled’’ from lactate-
producing cells (astrocytes) to lactate-consuming cells
(neurons) as an adaptive response to limit substrate
reduction and maximize energy production. There is also
experimental evidence that lactate is neuroprotective after
acute brain injury. In a recent prospective study, multi-
modal brain monitoring was used to investigate the
metabolic and hemodynamic effects of exogenous
administration of hypertonic sodium lactate in 15 patients
with severe TBI [39]. Lactate administration resulted in a
statistically significant increase in cerebral microdialysis-
monitored concentrations of lactate, pyruvate and glu-
cose, with a concomitant reduction in glutamate and ICP.
Taken together these data suggest that exogenous lactate
can be utilized as a preferential and efficient energy
source by the injured human brain, with resultant sparing
of cerebral glucose.
Nutrition in the critically ill patient
Singer et al. [40] expressed their vision regarding nutri-
tion in a ‘‘What’s New in Intensive Care’’ article. These
authors pointed out the increasing body of evidence
demonstrating the benefits of early enteral feeding and
raised concerns regarding overfeeding and the use of
predictive equations to target nutritional requirements.
Hickmann et al. [41] explored changes in resting energy
expenditure (REE) during sepsis and exercise, and they
too described the poor accuracy of the more frequently
used predictive equations, as well as demonstrating a
strong correlation between measured REE and C-reactive
protein levels. Thus, in their study, REE was increased in
the presence of active exercise was present, while passive
exercise was not associated with an increased REE. These
findings are helpful since passive exercise is more often
used than active exercise to prevent muscle loss in criti-
cally ill patients.
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Regarding specific nutrients, Singer et al. [40] rec-
ommended that glutamine should be administered
intravenously (IV glutamine) to patients requiring par-
enteral nutrition except if they suffer from organ failures
involving liver or kidneys. They also suggested that
supplemental n-3 fatty acids (10 g/day of omega-3 fatty
acids) be continuously administered enterally in patients
suffering from ARDS as this has been associated with
improvement in the PaO2/FIO2 ratio (ratio of arterial
oxygen partial pressure to fractional inspired oxygen) and
a decrease in the length of ventilation. Nevertheless, when
administered in larger doses and as a bolus, the results
were not confirmed. Perez-Barcena et al. [42] studied the
effects of IV glutamine in a trauma population. These
authors did not find a clinical advantage to this treatment,
possibly related to the fact that the dose administered did
increase plasma levels above normal values in 39 % of
the treated group who started with very low plasma levels
at baseline. This study reinforces the hypothesis that
administration of specific nutrients should be guided by
adequate levels to ensure clinical efficacy. Identical
conclusions were reached by Nie et al. [43] regarding the
administration of eicosapentaenoic acid (EPA) and
gamma-linolenic acid (GLA) in critically ill patients
suffering from ARDS. This meta-analysis of a mix of
studies with continuous/bolus enteral administration of
various doses of mainly EPA, but also DHA and/or GLA,
did not show any advantage in terms of mortality or
length of ventilation or ICU stay. However, improvement
in the PaO2/FIO2 ratio at days 4 and 7 were found, sug-
gesting some pharmacological effects. Continuous enteral
administration appeared to be superior to high-dose bolus
administration.
While studies of tight glucose control in patients have
failed to be reproducible on a large scale, hyperglycemia
remains of concern. Deane et al. [44] observed acute
hyperglycemia in 1,000 critically ill patients and found
that the risk of death increased by 20 % for each increase
in acute glycemia of 1 mmol/l for patients with diabetes
and a glycated hemoglobin (HbA1C) of \7 % before
admission. This association was lost in diabetics patients
with HbA1C [7 % who were poorly controlled. These
findings are helpful to understand some discrepancies in
the current literature. Daviaud et al. [45] studied patients
undergoing an OHCA and resuscitation who were
admitted to a large CA center in France. Patients with a
relatively higher level of blood glucose level at admission
had a worse outcome, and the increase in the median
blood glucose level over the first 48 h was found to be an
independent predictor of poor outcome [odds ratio
(OR) 0.43, 95 % confidence interval (CI) 0.24–0.78,
p \ 0.006]. The authors suggested testing a strategy
combining both control of glycemia and minimization of
glucose variability to improve post-resuscitation care.
Finally. the routine measurement of gastric residue
volume has recently been challenged [40]. Hamada et al.
[46] discuss an innovative way of measuring the gastric
residual volume using ultrasonography which they
showed to be accurate when compared to CT volumetric
assessment of gastric content. These authors found a good
correlation in many cases and suggested that this tech-
nique could be easily used at the bedside to assess patients
at risk of large gastric residuals and aspiration, as well as
to evaluate how the enteral nutrition is tolerated. Krag
et al. [47] attempted to find evidence for stress ulcer
prophylaxis using H2 blockers in 12 trials and proton-
pump inhibitors (PPIs) in two studies, mostly intrave-
nously (19 out of 20 trials included). Although no
difference in ICU mortality was observed, there was a
significant decrease in gastrointestinal bleeding when
compared to the control. However, this finding could not
be confirmed in an analysis of trials with adequate ran-
dom sequence generation, allocation concealment and
blinding (n = 1), raising questions on the quality of the
studies. No difference in nosocomial pneumonia was
observed. Interestingly, enteral feeding alone was not
associated with an increased incidence of ventilator-
associated pneumonia, suggesting that enteral feeding
may be sufficient to prevent upper gastrointestinal
bleeding.
Acute kidney injury
After 10 years in development, publication of the widely
accepted Kidney Disease: Improving Global Outcomes
(KDIGO) clinical practice guidelines for AKI has resulted
in standardization of the diagnosis and staging of AKI
[48]. However, validation of this classification is still
missing in the pediatric population. Applying the KDIGO
criteria on 3,009 patients from the University of Michigan
Pediatric Critical Care Database, Selewski and co-work-
ers [49] demonstrated an incidence of AKI of 24.5 %,
with the majority of patients reaching AKI stage 3. This is
currently among the largest pediatric cohort investigated
for this syndrome, with the patient cohort comprising
newborns and children aged up to 14 years. As has
already demonstrated for adult patients, these authors
found that AKI stage in their pediatric patients was sig-
nificantly associated with increased length of stay,
requirement of mechanical ventilation and mortality (OR
3.4, 95 % CI 2.0–6.0).
Sepsis is known as the major cause of AKI in critically
ill patients [50], and recent research has provided new
insights into the poorly understood pathophysiology of
this entity. It would appear that reduced renal blood flow
or renal ischemia is not a major component of a reduced
glomerular filtration rate (GFR) in sepsis. Renal inflam-
matory and immunologic mechanisms appear to result in
tubular cell injury, most likely mediated by damage or
pathogen-associated molecular patterns [pathogen-
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associated molecular pattern molecules (PAMPs) and
damage/danger-associated molecular pattern molecules
(DAMPs)] which are filtered at the glomerulum and rec-
ognized by renal tubular cells via several receptors, such
as toll-like receptor 4. The resulting overexpression of
NF-kB and subsequent release of tumor necrosis factors
and other cytokines lead to reduced sodium reabsorption,
activation of tublo-glomerular feedback and further
tubular cell injury. Eventually all these factors contribute
to a loss of GFR and septic AKI [51]. Furthermore, a
retrospective analysis of a large international multicenter
database including 4,493 patients with septic shock found
the development of AKI, which occurred in roughly 73 %
of these patients, did not depend on the causal pathogen
[52]. Although pulmonary infections were by far the
leading cause of septic shock, a multivariate analysis fully
adjusted for age, comorbidities and severity of disease
showed that major risk factor appears to be the site
infection, with urinary tract infection carrying the highest
risk of AKI (OR 2.35, 95 % CI 1.78–3.09) followed by
gastrointestinal and blood stream infections (each with an
average OR of 1.5).
Prevention of AKI in both sepsis and non-sepsis-
associated critical illness primarily depends on avoiding
additional harm to the kidney [48, 53]. A previously
underestimated risk factor may be the type of fluid used
during volume resuscitation. Recent large randomized
trials on fluid resuscitation in patients with sepsis [54, 55]
as well as in other critically ill patients [56] revealed that
hydroxethylstarch (HES) carries a significant risk for AKI
as well as the requirement for RRT. There even appears to
be a sign of increased mortality [57, 58], which initially
led the European Medicines Agency (EMA) to recom-
mend suspension of the licensing for HES in all
indications. This recommendation was subsequently
partly withdrawn, to allow the use of starches in severe
hemorrhage in trauma and during surgery at the discretion
of the treating physician. This decision is questioned in
depth by six experts of the EMA in a commentary pub-
lished in ‘‘What’s New in Intensive Care?’’ [59], who
stress that continuing the use of HES means exposing a
large number of patients to significant risk with poten-
tially detrimental consequences. This commentary is
supported by a systematic review investigating tissue
deposition of HES [60]. Extracting data from 37 human
(total 635 patients) and 11 animal studies, the authors
demonstrated a significant accumulation of HES in sev-
eral tissues, most predominantly in kidneys but also in
relevant amounts in liver, bone marrow and skin. Addi-
tional sites of HES deposition were lymph nodes, spleen,
lung pancreas, intestine, muscle, trophoblast and placental
stroma. Interestingly, reports of (sometimes long-lasting)
pruritus mainly originate from studies where HES has
been applied for hemodilution as treatment of acute
hearing loss. HES uptake by the kidney could be observed
as early as 30 min after infusion. Storage in organs was
cumulative and increased with increases in the amount of
HES administered; in some cases HES accumulation was
long-lasting, persisting more than 8 and 10 years in skin
and kidney, respectively. Remarkably, in 15 % of patients
HES storage and associated symptoms occurred already at
low doses of 0.4 g/kg body weight. An accompanying
editorial, however, addressed the issue of benefit versus
harm in an extremely valid manner. Colloids, at least
theoretically, should enable faster and more effective
intravascular volume expansion than colloids, with less
risk of volume overload as long as the glycocalix is not
significantly damaged. Thus, in early volume resuscita-
tion and hemodynamic instability which is not sufficiently
treatable with crystalloids, colloids may be the only
alternative to stabilize patients [61].
The issue of crystalloid administration also requires
intense scrutiny in the light of recent experimental
findings. The most frequently used crystalloid fluid is a
0.9 % sodium chloride solution (or ‘‘normal’’ saline).
This solution is far from being physiological, and its high
chloride content of 154 mmol/l has been found to induce
metabolic acidosis and vasoconstriction in the kidney,
reducing the GFR in healthy volunteers [62]. A recent
observational, before–after study showed that switching
from normal saline to more balanced solutions with
chloride contents of \110 mmol/l resulted in less AKI
and fewer requirements for RRT [63]. This aspect was
further investigated by a retrospective analysis of nearly
110,000 patients with systemic inflammatory response
syndrome (SIRS) treated with crystalloids [64]. The
authors of this study looked at mortality associated with
chloride administration (quantified as millimolar chloride
per liter of volume administration) and found that
patients receiving [500 mmol chloride had a signifi-
cantly increased mortality compared those receiving
100–200 mmol chloride ([10 vs. 3.5 %, respectively).
However, the effect was also dependent on the total
volume administered, and no negative effects of chloride
could be shown for patients receiving \1,500 ml of
fluids over a 72-h period. A multivariate analysis
adjusted for fluid volume and severity of disease char-
acterized by the Acute Physiology Score showed an
increased risk of mortality (OR 1.094, 95 % CI
1.062–1.127) with increasing volume adjusted for a
chloride load of [105 mmol/l. An accompanying edito-
rial [65], however, highlighted that although these
studies provide a signal of possible harm by normal
saline, treating physicians have to consider that the effect
appears to be dose dependent and that a randomized
controlled trial proving this assumption, although still
absent, is ongoing and the results expected soon. Until
these results are available, physicians continuing the use
of normal saline may be reassured by 150 years of
clinical experience in its use and the fact that more 7,000
ICU patients have received 0.9 % saline in randomized
controlled trials.
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The issue of volume overload was also investigated in
the very specific cohort of 172 patients requiring ECMO
for either refractory heart failure (n = 115) or refractory
respiratory failure (n = 57); about 60 % were also treated
with RRT. Positive fluid balance on day 3 of the ECMO
treatment turned out to be the most important predictor
for mortality in this vulnerable cohort. Future interven-
tional studies with the aim to limit positive fluid balance
will have to show whether modifying this risk factor
really does improve outcome.
Renal recovery after AKI is a recently emerging issue
with significant implications for all healthcare systems
[66]. Available data indicate that between 10 and 65 % of
critically patients requiring RRT who survive to discharge
may remain on chronic dialysis [67], although the largest
randomized trials on RRT show renal recovery rates at
60 days of between 7 and 25 % [68]. However, even
those patients who experienced AKI and never required
RRT and showed recovery may develop chronic kidney
disease later on and potentially end up on dialysis years
after discharge from hospital. This population currently
remains largely undetected [69]. A major problem may be
the use of estimated GFR (eGFR), which is mainly based
on serum creatinine levels. eGFR appears to overestimate
renal function in patients staying in the ICU for a longer
time. Such overestimation was nicely demonstrated in a
secondary analysis of the EPANIC trial, involving 757
patients, which showed that a reduction in creatinine
production was positively correlated with the length of
stay in the ICU, likely due to muscle loss [70]. In this
population, the discrepancy between measured creatinine
clearance and eGFR became apparent in patients staying
in the ICU for[7 days, was more pronounced after AKI,
but was also apparent in the group who did not experience
AKI. These results clearly indicate that without per-
forming a proper creatinine clearance test, [50 % of
patients with reduced renal function will be missed and
probably not followed up for renal function.
Hyponatremia, defined by a serum sodium concen-
tration of \135 mmol/l, is present in 15–20 % of
emergency admissions to hospital and occurs in up to
20 % of critically ill patients. Symptomatology may vary
from subtle to life threatening. Despite this, the man-
agement of patients remains problematic. Against this
background, the ESICM, the European Society of Endo-
crinology (ESE) and the European Renal Association–
European Dialysis and Transplant Association (ERA–
EDTA), represented by its new guidance body, the
European Renal Best Practice (ERBP), have developed a
Clinical Practice Guideline on the diagnostic approach
and treatment of hyponatremia as a joint venture of three
societies which represent specialists with a natural interest
in hyponatremia. A major focus was placed on the treat-
ment of acute hyponatremia, a life-threatening condition
characterized by coma, seizure, vomiting or severe
cardio-respiratory stress that requires urgent therapy by
the administration of hypertonic (3 %) saline [71].
Finally, the way in which intensive care medicine is
practiced is heavily influenced by the working circum-
stances of the critical care specialist and even more by the
region in which the ICU is found. Joynt and Tat [72]
present a quick overview of the most important ten dis-
eases a critical care specialist has to know when
practicing in Hong Kong. Of course severe acute respi-
ratory syndrome (SARS) is on top of the list but the
effects of traditional Chinese medicine toxicity should not
be underestimated.
Miscellaneous
Taccone et al. published a ‘‘What’s New in Intensive
Care?’’ paper on fever control in the ICU [73] in which
they reminded readers of the high prevalence of elevated
body temperature in critically ill patients and reviewed
and discussed the question of whether fever should
actually be treated. On the one hand, for patients with
infection, there is a relationship between early fever and
decreased mortality, suggesting a potential protective
effect of fever. On the other hand, this effect seems not to
persist at high temperature and in other conditions, such
as in acute lung injury where fever appears to be delete-
rious. However, evidence-based medical data for or
against treating fever are currently lacking, and results
have even been contradictory. More studies are expected:
the Heat study in critically ill patients with known or
suspected infection, the FACE II study in unselected
critically ill patients with fever and the CASS study in
septic shock patients.
Evaluation of the clinical result of practice in the ICU
is very important. In a large observational cohort study,
Galland et al. [74] evaluated the determinants of long- and
short-term survival in critical illness. A total of 33,324
initial ICU admissions were analyzed, showing mortality
rates within 30 and 90 days of 15.9 and 19.5 %, respec-
tively. The authors observed two phases of survival
related to critical illness: (1) short-term mortality, which
was mainly determined by the acute illness, but its effect
decayed relatively rapidly; (2) mortality beyond
3 months, among those who survived to that point, was
mainly determined by age and comorbidity. Recognition
of these findings is relevant to discussions with patients
and surrogates about achievable goals of care.
In a retrospective cohort study, Gantner et al. [75]
reported that after-hours discharge remains an important
independent predictor of hospital mortality and readmis-
sion to the ICU. These authors used the Australian and
New Zealand Intensive Care Society Adult Patient
Database (ANZICS APD) for patients admitted to
188
Australian and New Zealand ICUs between January 2005
and December 2012. Among the 710,535 patients ana-
lyzed, 15.4 % were discharged after hours (6 pm–6 am),
and these patients had a higher mortality than the others
(6.4 vs. 3.6 %, respectively). An interesting editorial by
Guidet and Bion [76], entitled ‘‘Night thoughts’’,
accompanies the paper.
Ghassemi et al. [77] from the Massachusetts Institute
of Technology proposed an original approach to optimize
unfractionated heparin (UFH) dosing, after having
emphasized that activated partial thromboplastin time
(aPTT) at 6 h after UFH infusion is frequently in the sub-
or supra-therapeutic range based on the usual guidelines.
Using the Multi-parameter Intelligent Monitoring in
Intensive Care II (MIMIC II) database, they analyzed
1,511 patients admitted to the ICU at the Beth Israel
Deaconess Medical Center who received heparin during
their ICU stay. These authors reported that race, ICU
type, gender, heparin dose, age and Sequential Organ
Failure Assessment score were associated with such
inappropriate aPTT. Using a complex statistical analysis,
they finally proposed a model, which has yet to be
formally validated, to predict the optimal dose of UFH
needed to achieve the target aPTT.
Data analysis and presentation are the foundations of
scientific research and dissemination, and appropriate
statistical methods are crucial. Intensive Care Medicine
frequently involves statistical reviewers at an early stage
of its review process to filter studies with suboptimal
design and those applying inappropriate or insufficiently
reported statistical methods. Poole et al. [78] use two
examples, namely, diagnostic test and meta-analysis
interpretation, to illustrate common statistical pitfalls.
They note that even when statistical analyses are appro-
priate and correct, authors have a tendency to
overemphasize their results and that this risks translation
into clinical practice of treatments for which the benefits
and risks have not be fully verified. Poole and colleagues
also note the important ethical role that statistical
reviewers play in minimizing this risk, but it is clear that
we all (authors, reviewers, journal editors and readers)
share this responsibility.
Conflicts of interest None.
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